ARK Genomic Revolution ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARKG and other ETFs, options, and stocks.

About ARKG

ARKG is an actively managed fund that targets companies involved in the genomics industry. 

Category
Health
CategoryHealth
Number of holdings
35
Number of holdings35
Inception Date
Oct 31, 2014
Inception DateOct 31, 2014

What's in this fund

Sectors

As of January 15, 2026
Healthcare100.00%

ARKG Key Statistics

AUM
1.35B
AUM1.35B
Price-Earnings ratio
-10.65
Price-Earnings ratio-10.65
30-Day yield
30-Day yield
Average volume
2.87M
Average volume2.87M
High today
$32.44
High today$32.44
Low today
$31.48
Low today$31.48
Open price
$32.15
Open price$32.15
Volume
2.04M
Volume2.04M
52 Week high
$34.07
52 Week high$34.07
52 Week low
$17.51
52 Week low$17.51
Expense ratio
0.75
Expense ratio0.75

Stock Snapshot

With a market cap of 1.33B, ARK Genomic Revolution ETF(ARKG) trades at $31.86. The stock has a price-to-earnings ratio of -10.65 and currently yields dividends of 3.2%.

During the trading session on 2026-01-17, ARK Genomic Revolution ETF(ARKG) shares reached a daily high of $32.44 and a low of $31.48. At a current price of $31.86, the stock is +1.2% higher than the low and still -1.8% under the high.

Trading volume for ARK Genomic Revolution ETF(ARKG) stock has reached 2.04M, versus its average volume of 2.87M.

Over the past 52 weeks, ARK Genomic Revolution ETF(ARKG) stock has traded between a high of $34.07 and a low of $17.51.

Over the past 52 weeks, ARK Genomic Revolution ETF(ARKG) stock has traded between a high of $34.07 and a low of $17.51.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .